WASHINGTON, DC—For patients who have heart failure with reduced ejection fraction (HFrEF) accompanied by moderate aortic stenosis (AS), there’s not much to gain by doing TAVI before the valve disease ...

Please provide your email address to receive an email when new articles are posted on . TAVR did not improve a composite of clinical endpoints in patients with moderate aortic stenosis and HFrEF.

MONTREAL – April 24, 2026 – A novel detection algorithm spotted moderate-to-severe aortic stenosis (AS) with a sensitivity of 90.5% of all patients and 100% of African American patients. Researchers ...

Findings from the TAVR UNLOAD study found limited benefits of transcatheter aortic valve replacement (TAVR) in the treatment of heart failure (HF) with reduced ejection fraction (HFrEF) and moderate ...

Findings from the TAVR UNLOAD study found limited benefits of transcatheter aortic valve replacement (TAVR) in the treatment of heart failure (HF) with reduced ejection fraction (HFrEF) and moderate ...

In asymptomatic patients with mild to moderate aortic stenosis, the survival is similar to age-matched controls. [1,16] The mainstay of medical treatment for these patients is simply appropriate ...

People living with aortic stenosis (AS) could gain earlier access to innovative care and treatment thanks to a new effort from the American Heart Association designed to boost clinical trial ...

Four-dimensional flow cardiovascular MRI (4D flow CMR) can more accurately estimate peak aortic valve velocities (V Peak) than traditional transthoracic echocardiography (TTE) in patients with aortic ...

Aortic stenosis (AS) is a narrowing of the aortic valve, most often caused by age-related calcium buildup. Severe AS can significantly obstruct blood flow and lead to symptoms like shortness of breath ...

Aortic stenosis is a valve disease in which the aortic valve narrows, restricting blood flow from the heart. High blood pressure is common with aortic stenosis because the heart must work harder to ...

WASHINGTON, DC – OCTOBER 28, 2024 – Findings from the TAVR UNLOAD study found limited benefits of transcatheter aortic valve replacement (TAVR) in the treatment of heart failure (HF) with reduced ...